Cargando…

Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft

Cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) is a critical enzyme involved in gluconeogenesis, glyceroneogenesis and cataplerosis. cPEPCK converts oxaloacetic acid (OAA) into phosphoenol pyruvate (PEP) in the presence of GTP. cPEPCK is known to be associated with type 2 diabetes. Genistein i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katiyar, Shashank Prakash, Jain, Arpit, Dhanjal, Jaspreet Kaur, Sundar, Durai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631375/ https://www.ncbi.nlm.nih.gov/pubmed/26528723 http://dx.doi.org/10.1371/journal.pone.0141987

Ejemplares similares

Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2015)

Wild type p53 function in p53(Y220C) mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
por: Sundar, Durai, et al.
Publicado: (2019)

A theoretical investigation of DNA dynamics and desolvation kinetics for zinc finger proteinZif268
por: Dutta, Shayoni, et al.
Publicado: (2015)

Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus
por: Grover, Sonam, et al.
Publicado: (2014)

PEPCK in cancer cell starvation
por: Leithner, Katharina
Publicado: (2015)

Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera
por: Grover, Abhinav, et al.
Publicado: (2012)

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019)

Identification and Characterization of Mortaparib(Plus)—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2021)

Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia
por: Rani, Lata, et al.
Publicado: (2017)

Mutant p53(L194F) Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib(Plus), a Multimodal Small Molecule Inhibitor
por: Elwakeel, Ahmed, et al.
Publicado: (2021)

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives
por: Malik, Vidhi, et al.
Publicado: (2020)

Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53(Y220C) mutant: bioinformatics and experimental evidence
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2021)

Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
por: Garg, Sukant, et al.
Publicado: (2019)

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1
por: Meidinna, Hazna Noor, et al.
Publicado: (2022)

Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
por: Wadhwa, Renu, et al.
Publicado: (2016)

Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and Mortaparib(Plus)
por: Kumar, Vipul, et al.
Publicado: (2021)

2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
por: Chaudhary, Anupama, et al.
Publicado: (2019)

Gluconeogenesis and PEPCK are critical components of healthy aging and dietary restriction life extension
por: Onken, Brian, et al.
Publicado: (2020)

Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
por: Hyroššová, Petra, et al.
Publicado: (2022)

Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
por: Sari, Anissa Nofita, et al.
Publicado: (2020)

A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2022)

Genistein from Vigna angularis Extends Lifespan in Caenorhabditis elegans
por: Lee, Eun Byeol, et al.
Publicado: (2015)

Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195
por: Yang, Won-Mo, et al.
Publicado: (2017)

Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
por: Zhang, Mingming, et al.
Publicado: (2017)

Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
por: Saxena, Nishant, et al.
Publicado: (2013)

TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow
por: Kalakoti, Yogesh, et al.
Publicado: (2022)

Deep Neural Network-Assisted Drug Recommendation Systems for Identifying Potential Drug–Target Interactions
por: Kalakoti, Yogesh, et al.
Publicado: (2022)

SurvCNN: A Discrete Time-to-Event Cancer Survival Estimation Framework Using Image Representations of Omics Data
por: Kalakoti, Yogesh, et al.
Publicado: (2021)

Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2021)

Multi-Scale Characterization of the PEPCK-C(mus) Mouse through 3D Cryo-Imaging
por: Roy, Debashish, et al.
Publicado: (2010)

Endurance Capacity, Not Body Size, Determines Physical Activity Levels: Role of Skeletal Muscle PEPCK
por: Novak, Colleen M., et al.
Publicado: (2009)

Involvement of KLF11 in Hepatic Glucose Metabolism in Mice via Suppressing of PEPCK-C Expression
por: Zhang, Huabing, et al.
Publicado: (2014)

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca(2+)
por: Moreno-Felici, Juan, et al.
Publicado: (2019)

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner
por: Hyroššová, Petra, et al.
Publicado: (2021)

Hybrid Multitask Learning Reveals Sequence Features Driving Specificity in the CRISPR/Cas9 System
por: Vora, Dhvani Sandip, et al.
Publicado: (2023)

Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy
por: Baptista, Luiz Phillippe R, et al.
Publicado: (2019)

Millisecond mix-and-quench crystallography (MMQX) enables time-resolved studies of PEPCK with remote data collection
por: Clinger, Jonathan A., et al.
Publicado: (2021)

Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation
por: Zhu, Yu-Xian, et al.
Publicado: (2021)

‘Location, Location, Location’: a spatial approach for rare variant analysis and an application to a study on non-syndromic cleft lip with or without cleft palate
por: Fier, Heide, et al.
Publicado: (2012)

Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
por: Nigam, Nupur, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kr1b36ghgete2ghm52e1ru05ih